查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1565600

人工視網膜植入的全球市場:產品·用途·終端用戶·不同地區的預測 (～2032年)

Global Artificial Retina Implant Market Research Report Information by Product, by Application, and by End User and by Region - Forecast till 2032
出版日期: | 出版商: Market Research Future | 英文 77 Pages | 訂單完成後即時交付

價格

全球視網膜假體植入市場規模預計將從2025年的15.1億美元成長到2026年的19.2億美元，預測期內複合年增長率為21.22%，到2032年將達到70億美元。至4000 萬美元。

視網膜色素變性和老年黃斑部病變 (AMD) 盛行率的上升以及提供視網膜假體植入的新創公司數量的增加是推動全球市場擴張的主要原因。

區域展望

2025年北美市佔率超過50.12%。由於老年黃斑部病變 (AMD) 盛行率不斷上升以及 FDA 批准的植入產品的可用性，北美視網膜假體植入市場佔據了最大佔有率。

預計 2025 年至 2026 年歐洲市場將大幅擴張。這主要是因為進入者經常結成策略聯盟來滿足顧客需求。

亞太地區視網膜假體市場預計在預測期內將以最快的速度發展。這是由於該地區老年人口不斷增長，預計這將對該行業的成長做出重大貢獻。根據《2022年亞太人口老化報告》，預計到2022年，亞太地區60歲及以上的人口將超過6.7億人。到 2050 年，亞太地區的人口預計將增加兩倍，達到約 13 億。

本報告提供全球人工視網膜植入的市場調查，彙整市場定義和概要，市場成長的各種影響因素分析，市場規模的轉變·預測，各種區分·各地區的明細，競爭環境，主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 市場概要

第3章 調查手法

第4章 市場動態

  • 促進因素
    • 老年黃斑部病變 (AMD) 和色素性視網膜炎的發生率不斷增加
  • 阻礙因素
    • 與視網膜假體植入手術相關的高成本
  • 機會
    • 增加視網膜假體植入的資金和投資

第5章 市場要素分析

  • 波特的五力分析
  • 開發大腦植入物治療視力喪失的領導公司

第6章 全球人工視網膜植入市場:各產品類型

  • 概要
  • 視網膜上植入
  • 視網膜下植入
  • 脈絡薄膜上植入

第7章 全球人工視網膜植入市場:各用途

  • 概要
  • 老年性黃斑部病變 (AMD)
  • 色素性視網膜炎

第8章 全球人工視網膜植入市場:各地區

  • 概要

第9章 競爭情形

  • 競爭儀表板
  • 上市公司的股票概要
  • 比較分析:主要企業的財務趨勢
  • 主要的展開·成長策略

第10章 企業簡介

  • VIVANI MEDICAL INC.
  • IBIONICS
  • NANOVISION BIOSCIENCES
  • SENSOR-TECH LAB
  • LABTICIAN OPHTHALMICS, INC
  • OPTOBIONICS
  • LAMBDAVISION, INC.
  • BIONIC VISION TECHNOLOGIES
  • PIXIUM VISION
  • AXORUS
  • DATA CITATIONS
Product Code: MRFR/MED/2095-CR

Global Artificial Retina Implant Market Research Report Information by Product (Enzymes, Pharma Products, Bulk Chemicals, and Others), by Application (Bioengineering, Genomics, Vaccine Development, Drug Discovery, Fisheries, Aquaculture, Biofuels, Water Treatment Services, and Others), and by End User (Hospitals, Pharmaceutical Companies, Biotechnology Companies, and Others) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032

Market Synopsis

The market for artificial retinal implants was estimated to be worth USD 1.51 billion in 2025. The Artificial Retina Implant market is expected to expand at a compound annual growth rate (CAGR) of 21.22% between 2026 and 2032, from USD 1.92 billion in 2026 to USD 7.04 billion.

The rising prevalence of retinitis pigmentosa and age-related macular degeneration (AMD), as well as the rise in the number of startups offering artificial retina implants, are the main reasons propelling the expansion of the global market.

In September 2021, Bionic Vision Technologies, a well-known brand in artificial retina technology, announced a significant collaboration with Cirtec Medical, a top medical technology business with its headquarters located in the US. The collaborative effort will facilitate the design process and allow for cooperative production of the next generation of bionic eyes. With the resources and expertise base of Cirtec Medical at its disposal, Bionic Vision Technologies hopes to advance its cutting-edge bionic eye technology and provide improved vision solutions for those with visual impairments.

Insights on Market Segments

The Artificial Retina Market is divided into three segments based on product type: suprachoroidal implants, subretinal implants, and epiretinal implants.

The artificial retina market has been divided into two segments based on application: retinitis pigmentosa and age-related macular degeneration (AMD).

Regional Perspectives

The market is divided into four regions by the study: North America, Europe, Asia-Pacific, and the Rest of the World. With a market share of more than 50.12% in 2025, the artificial retina implant market in North America held the biggest share due to the rising prevalence of age-related macular degeneration (AMD) and the availability of FDA-approved implant products. For example, Argus II is a product that the FDA has approved and is accessible in the United States.

The artificial retina implant market in Europe is expected to increase significantly between 2025 and 2026, primarily due to the frequent strategic alliances formed by industry participants to meet customer demand. For example, Pixium Vision (France) revealed in July 2022 that the first patient in the Netherlands had a successful implantation in the Prima System European pivotal trial PRIMAvera. Since then, Pixium Vision has created more clinical locations and implanted patients in the UK and Germany.

The Asia-Pacific artificial retina implant market is expected to develop at the quickest rate during the forecast period due to the region's growing geriatric population, which is expected to significantly contribute to the industry's growth. For example, the Asia-Pacific Report on Population Ageing 2022 estimates that 670 million or more persons in Asia-Pacific were 60 years of age or older in 2022. In the Asia-Pacific region, the population is predicted to treble to almost 1.3 billion by 2050.

Key Players

Bionic Vision Technologies (US), PIXIUM VISION (France), Optobionics (US), Labtician Ophthalmics, Inc. (Canada), Vivani Medical Inc. (US), iBIONICS (Canada), LambdaVision, Inc. (US), AXORUS (France), Sensor-Tech Lab (Russia), and Nanovision (US) are some of the prominent companies in the artificial retina implant market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE AND ASSUMPTIONS
  • 2.5 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
    • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TECHNIQUE
  • 3.8 DATA MODELING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA MODELING:

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 INCREASING INCIDENCES OF AGE-RELATED MACULAR DEGENERATION (AMD) AND RETINITIS PIGMENTOSA
    • 4.2.2 GROWING NUMBER OF STARTUPS ASSOCIATED WITH ARTIFICIAL RETINA IMPLANT
  • 4.3 RESTRAINTS
    • 4.3.1 HIGH COST ASSOCIATED WITH ARTIFICIAL RETINA IMPLANT PROCEDURES
  • 4.4 OPPORTUNITY
    • 4.4.1 INCREASING FUNDING & INVESTMENT FOR ARTIFICIAL RETINA IMPLANT

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 THREAT OF SUBSTITUTES
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF RIVALRY
  • 5.2 KEY PLAYERS DEVELOPING BRAIN IMPLANTS TO TREAT VISION LOSS

6 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY PRODUCT TYPE

  • 6.1 OVERVIEW
  • 6.2. EPIRETINAL IMPLANTS
  • 6.3. SUBRETINAL IMPLANTS
  • 6.4. SUPRACHOROIDAL IMPLANTS

7 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2. AGE-RELATED MACULAR DEGENERATION (AMD)
  • 7.3. RETINITIS PIGMENTOSA

8 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY REGION

  • 8.1 OVERVIEW

9 COMPETITIVE LANDSCAPE

  • 9.1 INTRODUCTION
  • 9.2 COMPETITOR DASHBOARD
  • 9.3 PUBLIC PLAYERS STOCK SUMMARY
  • 9.4 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 9.5 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 9.5.1 PARTNERSHIP
    • 9.5.2 EXPANSION
    • 9.5.3 MERGER

10 COMPANY PROFILES

  • 10.1 VIVANI MEDICAL INC.
    • 10.1.1 COMPANY OVERVIEW
    • 10.1.2 FINANCIAL OVERVIEW
    • 10.1.3 PRODUCTS OFFERED
    • 10.1.4 KEY DEVELOPMENTS
    • 10.1.5 SWOT ANALYSIS
    • 10.1.6 KEY STRATEGIES
  • 10.2 IBIONICS
    • 10.2.1 COMPANY OVERVIEW
    • 10.2.2 FINANCIAL OVERVIEW
    • 10.2.3 PRODUCTS OFFERED
    • 10.2.4 KEY DEVELOPMENTS
    • 10.2.5 SWOT ANALYSIS
    • 10.2.6 KEY STRATEGY
  • 10.3 NANOVISION BIOSCIENCES
    • 10.3.1 COMPANY OVERVIEW
    • 10.3.2 FINANCIAL OVERVIEW
    • 10.3.3 PRODUCTS OFFERED
    • 10.3.4 KEY DEVELOPMENTS
    • 10.3.5 KEY STRATEGY
  • 10.4 SENSOR-TECH LAB
    • 10.4.1 COMPANY OVERVIEW
    • 10.4.2 FINANCIAL OVERVIEW
    • 10.4.3 PRODUCTS OFFERED
    • 10.4.4 KEY DEVELOPMENTS
    • 10.4.5 KEY STRATEGY
  • 10.5 LABTICIAN OPHTHALMICS, INC
    • 10.5.1 COMPANY OVERVIEW
    • 10.5.2 FINANCIAL OVERVIEW
    • 10.5.3 PRODUCTS OFFERED
    • 10.5.4 KEY DEVELOPMENTS
    • 10.5.5 SWOT ANALYSIS
    • 10.5.6 KEY STRATEGIES
  • 10.6 OPTOBIONICS
    • 10.6.1 COMPANY OVERVIEW
    • 10.6.2 FINANCIAL OVERVIEW
    • 10.6.3 PRODUCTS OFFERED
    • 10.6.4 KEY DEVELOPMENTS
    • 10.6.5 KEY STRATEGIES
  • 10.7 LAMBDAVISION, INC.
    • 10.7.1 COMPANY OVERVIEW
    • 10.7.2 FINANCIAL OVERVIEW
    • 10.7.3 PRODUCTS OFFERED
    • 10.7.4 KEY DEVELOPMENTS
    • 10.7.5 SWOT ANALYSIS
    • 10.7.6 KEY STRATEGIES
  • 10.8 BIONIC VISION TECHNOLOGIES
    • 10.8.1 COMPANY OVERVIEW
    • 10.8.2 FINANCIAL OVERVIEW
    • 10.8.3 PRODUCTS/SERVICES OFFERED
    • 10.8.4 KEY DEVELOPMENTS
    • 10.8.5 KEY STRATEGIES
  • 10.9 PIXIUM VISION
    • 10.9.1 COMPANY OVERVIEW
    • 10.9.2 FINANCIAL OVERVIEW
    • 10.9.3 PRODUCTS OFFERED
    • 10.9.4 KEY DEVELOPMENTS
    • 10.9.5 SWOT ANALYSIS
    • 10.9.6 KEY STRATEGIES
  • 10.10 AXORUS
    • 10.10.1 COMPANY OVERVIEW
    • 10.10.2 FINANCIAL OVERVIEW
    • 10.10.3 PRODUCTS OFFERED
    • 10.10.4 KEY DEVELOPMENTS
    • 10.10.5 KEY STRATEGIES
  • 10.11 DATA CITATIONS

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY PRODUCT TYPE, 2025-2032 (USD THOUSAND)
  • TABLE 3 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY APPLICATION, 2025-2032 (USD THOUSAND)
  • TABLE 4 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, 2025-2032 (USD THOUSAND)
  • TABLE 5 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY REGION, 2025-2032 (USD THOUSAND)
  • TABLE 6 PUBLIC PLAYERS STOCK SUMMARY
  • TABLE 7 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • TABLE 8 PARTNERSHIP
  • TABLE 9 EXPANSION
  • TABLE 10 MERGER
  • TABLE 11 VIVANI MEDICAL, INC.: PRODUCTS OFFERED
  • TABLE 12 VIVANI MEDICAL, INC.: KEY DEVELOPMENTS
  • TABLE 13 IBIONICS: PRODUCTS OFFERED
  • TABLE 14 NANOVISON: PRODUCTS OFFERED
  • TABLE 15 SENSOR-TECH LAB: PRODUCTS OFFERED
  • TABLE 16 LABTICIAN OPHTHALMICS, INC: PRODUCTS OFFERED
  • TABLE 17 OPTOBIONICS: PRODUCTS OFFERED
  • TABLE 18 LAMBDAVISION, INC.: PRODUCTS OFFERED
  • TABLE 19 BIONIC VISION TECHNOLOGIES: PRODUCTS OFFERED
  • TABLE 20 BIONIC VISION TECHNOLOGIES: KEY DEVELOPMENTS
  • TABLE 21 PIXIUM VISION: PRODUCTS OFFERED
  • TABLE 22 PIXIUM VISION: KEY DEVELOPMENTS
  • TABLE 23 AXORUS: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET: STRUCTURE
  • FIGURE 2 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET: MARKET GROWTH FACTOR ANALYSIS
  • FIGURE 3 PORTER'S FIVE FORCES ANALYSIS: GLOBAL ARTIFICIAL RETINA IMPLANT MARKET
  • FIGURE 4 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, PRODUCT TYPE SEGMENT ATTRACTIVENESS, 2025 & 2032 (USD THOUSAND)
  • FIGURE 5 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY PRODUCT TYPE, 2025 & 2032 (USD THOUSAND)
  • FIGURE 6 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET SHARE, BY PRODUCT TYPE, 2025 (% SHARE)
  • FIGURE 7 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2025 & 2032 (USD THOUSAND)
  • FIGURE 8 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY APPLICATION, 2025 & 2032 (USD THOUSAND)
  • FIGURE 9 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY REGION, 2025 & 2032 (USD THOUSAND)
  • FIGURE 10 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET SHARE, BY REGION, 2025 (% SHARE)
  • FIGURE 11 COMPETITOR DASHBOARD: ARTIFICIAL RETINA MARKET
  • FIGURE 12 VIVANI MEDICAL, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 13 VIVANI MEDICAL, INC.: SWOT ANALYSIS
  • FIGURE 14 IBIONICS: SWOT ANALYSIS
  • FIGURE 15 LABTICIAN OPHTHALMICS, INC: SWOT ANALYSIS
  • FIGURE 16 LAMBDAVISION, INC.: SWOT ANALYSIS
  • FIGURE 17 PIXIUM VISION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 18 PIXIUM VISION: SWOT ANALYSIS